[Leukemia cutis arising at the site of injection of a tetanus vaccine booster]

Actas Dermosifiliogr. 2010 Oct;101(8):727-9.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antigens, CD / analysis
  • Antigens, Differentiation, Myelomonocytic / analysis
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow / pathology
  • Cytarabine / administration & dosage
  • Etoposide / administration & dosage
  • Fatal Outcome
  • Humans
  • Idarubicin / administration & dosage
  • Immunization, Secondary
  • Leukemia, Myelomonocytic, Chronic / diagnosis
  • Leukemia, Myelomonocytic, Chronic / drug therapy
  • Leukemia, Myelomonocytic, Chronic / pathology*
  • Leukemia, Myelomonocytic, Chronic / radiotherapy
  • Leukemic Infiltration / diagnosis*
  • Leukemic Infiltration / drug therapy
  • Leukemic Infiltration / etiology
  • Leukemic Infiltration / pathology
  • Leukemic Infiltration / radiotherapy
  • Leukosialin / analysis
  • Male
  • Middle Aged
  • Radiotherapy, Adjuvant
  • Shock, Septic / etiology
  • Skin / pathology*
  • Tetanus Toxoid / administration & dosage
  • Tetanus Toxoid / adverse effects*

Substances

  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD68 antigen, human
  • Leukosialin
  • SPN protein, human
  • Tetanus Toxoid
  • Cytarabine
  • Etoposide
  • Idarubicin